Half-year report · HY
7317.TEDINET S100X0JU
Period2025-04-01 → 2025-09-30
Filed2025-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.5bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥9.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.9bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥1.0bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.1bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.1bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥861m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥796m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥861m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥796m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥11.0bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥10.9bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥11.0bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.1bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥4.0bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥6.9bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.9bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.2bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.2bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.1bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.2bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥809m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥154m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥746m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥414m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥295m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥38m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥34m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥40.34 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥73.38 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.49 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥40 | 2025-04-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥72.55 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥37.05 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 62.8% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2025-04-01 → 2025-09-30 | ¥92m |
| Otherother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥92m |
| Otherother segments | segment profit | 2025-04-01 → 2025-09-30 | −¥19m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥183m |
| Medical Healthcarereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| Medical Healthcarereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| Medical Healthcarereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥975m |
| Safetysystemreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.4bn |
| Safetysystemreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.4bn |
| Safetysystemreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥254m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥4.5bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥4.5bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥1.2bn |
| Otherother segments | revenue | 2024-04-01 → 2024-09-30 | ¥77m |
| Otherother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥77m |
| Otherother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥25m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥152m |
| Medical Healthcarereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Medical Healthcarereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Medical Healthcarereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥924m |
| Safetysystemreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Safetysystemreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Safetysystemreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥265m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.9bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.9bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥1.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 475
| Item | Context | Value | Unit |
|---|---|---|---|
| Other cl | Prior1YearInstant | 140698000 | JPY |
| Other cl | InterimInstant | 121705000 | JPY |
| Current liabilities | Prior1YearInstant | 2114146000 | JPY |
| Current liabilities | InterimInstant | 2303980000 | JPY |
| Long term loans payable | Prior1YearInstant | 1450000000 | JPY |
| Long term loans payable | InterimInstant | 1396000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 95599000 | JPY |
| Net defined benefit liability | InterimInstant | 99921000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 90359000 | JPY |
| Deferred tax liabilities | InterimInstant | 96190000 | JPY |
| Other ncl | Prior1YearInstant | 225306000 | JPY |
| Other ncl | InterimInstant | 192684000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 1861265000 | JPY |
| Noncurrent liabilities | InterimInstant | 1784796000 | JPY |
| Liabilities | Prior1YearInstant | 3975411000 | JPY |
| Liabilities | InterimInstant | 4088777000 | JPY |
| Capital stock | Prior1YearInstant | 36088000 | JPY |
| Capital stock | InterimInstant | 40757000 | JPY |
| Capital surplus | Prior1YearInstant | 525985000 | JPY |
| Capital surplus | InterimInstant | 530654000 | JPY |
| Retained earnings | Prior1YearInstant | 5502343000 | JPY |
| Retained earnings | InterimInstant | 6150400000 | JPY |
| Treasury stock | Prior1YearInstant | -479000 | JPY |
| Treasury stock | InterimInstant | -479000 | JPY |
| Shareholders equity | Prior1YearInstant | 6063938000 | JPY |
| Shareholders equity | InterimInstant | 6721333000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 868289000 | JPY |
| Foreign currency translation adjustment | InterimInstant | 176924000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 868289000 | JPY |
| Valuation and translation adjustments | InterimInstant | 176924000 | JPY |
| Net assets | Prior1YearInstant | 6932227000 | JPY |
| Net assets | InterimInstant | 6898257000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 10907639000 | JPY |
| Liabilities and net assets | InterimInstant | 10987034000 | JPY |
| Net sales | Prior1InterimDuration | 4932198000 | JPY |
| Net sales | InterimDuration | 4539197000 | JPY |
| Cost of sales | Prior1InterimDuration | 3374658000 | JPY |
| Cost of sales | InterimDuration | 2992668000 | JPY |
| Gross profit | Prior1InterimDuration | 1557540000 | JPY |
| Gross profit | InterimDuration | 1546529000 | JPY |
| Selling general and administrative expenses | Prior1InterimDuration | 494962000 | JPY |
| Selling general and administrative expenses | InterimDuration | 518694000 | JPY |
| Operating income | Prior1InterimDuration | 1062577000 | JPY |
| Operating income | InterimDuration | 1027834000 | JPY |
| Interest income noi | Prior1InterimDuration | 3115000 | JPY |
| Interest income noi | InterimDuration | 5265000 | JPY |
| Dividends income noi | Prior1InterimDuration | 0 | JPY |
| Dividends income noi | InterimDuration | 0 | JPY |
| Foreign exchange gains noi | Prior1InterimDuration | 38981000 | JPY |
| Foreign exchange gains noi | InterimDuration | 92154000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |